Bromopride
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Bromopride.svg | |
| Bromopride
| |
| Systematic (IUPAC) name | |
| 4-amino-5-bromo-N-(2-diethylaminoethyl)- 2-methoxybenzamide | |
| Identifiers | |
| CAS number | |
| ATC code | A03 |
| PubChem | |
| Chemical data | |
| Formula | C14H22BrN3O2 |
| Mol. mass | 344.248 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 50 to 75% (oral) 78% (intramuscular) |
| Protein binding | 40% |
| Metabolism | Hepatic |
| Half life | 4 to 5 hours |
| Excretion | Renal, 10 to 14% unchanged |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral, IM, IV |
Bromopride (INN) is a dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide. It is not available in the United States.
Bromopride appears to be safe and effective for use in pregnancy.[1]
Indications
Bromopride is indicated in the treatment of nausea and vomiting, including postoperative nausea and vomiting (PONV); gastroesophageal reflux disease (GERD/GORD); and as preparation for endoscopy and radiographic studies of the gastrointestinal tract. The manufacturer also claims it is valuable in, among other indications, hiccups and gastrointestinal adverse effects of radiation therapy.
Adverse effects
Bromopride is generally well tolerated; the most common adverse effects of its use are somnolence and fatigue. Bromopride may rarely cause extrapyramidal symptoms and, as metoclopramide, may increase prolactin levels.[2]
Chemistry
Bromopride is a substituted benzamide, closely related to metoclopramide.[3] It is identical to metoclopramide except for the presence of a bromine atom where metoclopramide has a chlorine substituent.
Availability
Bromopride is not available in the United States or the United Kingdom. It is marketed in Brazil by Sanofi-Synthélabo under the trade name Digesan and as a generic drug.
References
- ↑ Araújo JR (1981). "Evaluation of bromopride in nausea and vomiting of pregnancy" (in Portuguese). J Bras Ginecol 91 (4): 283–5.
- ↑ Bula do Profissional de Saúde: Bromoprida (Portuguese). Bulário Eletrônico da Anvisa. Brazilian National Health Surveillance Agency (April 11 2006). Retrieved on 2007-07-23.
- ↑ Brodie RR, Chasseaud LF, Darragh A, Lambe RF, Rooney L, Taylor T (1986). "Pharmacokinetics and bioavailability of the anti-emetic agent bromopride". Biopharm Drug Dispos 7 (3): 215–22. doi:10.1002/bdd.2510070302. PMID 3730521.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
